This webinar explores how the Covaris truXTRAC® FFPE kit, powered by Adaptive Focused Acoustics® (AFA®), enabled OmniSeq to improve overall comprehensive molecular and immune profiling of patient tumors using a novel process for automated DNA and RNA extraction.
*OmniSeq, Inc., is a CAP accredited molecular diagnostic laboratory and subsidiary of Roswell Park Comprehensive Cancer center. Their mission is to deliver superior results by improving access to better cancer treatment options through comprehensive molecular profiling.
Hauptman Woodward Medical Research Institute
700 Ellicott St
Buffalo, NY 14203